SEC INSIDER TRANSACTIONS

ELI LILLY & Co (LLY) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

LLY · ELI LILLY & Co

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 42 filings · fetched 2026-11-13T18:38:39Z

Recent reported activity

0purchase rows on this page

4sale rows on this page

54matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-09-21Filed 2026-09-22	LUCIANO JUAN RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	13.6637A	1,164.89	Direct	Form 4 ↗0000059478-26-000091
2026-09-21Filed 2026-09-22	Fyrwald J ErikDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	8.513A	1,164.89	Direct	Form 4 ↗0000059478-26-000089
2026-09-09Filed 2026-09-11	Seymour MelissaOfficer · EVP, Global Quality Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was inadvertently not reported on a Form 4 at the time it occurred. References:	G GiftCommon Stock · Non-derivative	12D	0	Direct	Form 4 ↗0002032089-26-000004
2026-09-02Filed 2026-09-04	Dozier EricOfficer · EVP, Chief People Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	G GiftCommon Stock · Non-derivative	216D	0	Direct	Form 4 ↗0001955972-26-000008
2026-09-02Filed 2026-09-04	Hernandez EdgardoOfficer · EVP & Pres., Mfg. Operations Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	G GiftCommon Stock · Non-derivative	13D	0	Direct	Form 4 ↗0001861052-26-000006
2026-08-17Filed 2026-08-18	Jonsson PatrikOfficer · EVP & President, LLY Int'l Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2026 References: F1	S Sale (market/private)Common Stock · Non-derivative	6,500D	1,175.1	Direct	Form 4 ↗0001786054-26-000006
2026-08-17Filed 2026-08-18	Alvarez RalphDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. References: F1	A Award / grantCommon Stock · Non-derivative	10.4945A	1,183.16	Direct	Form 4 ↗0001310215-26-000015
2026-08-17Filed 2026-08-18	Sulzberger GabrielleDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	4.1908A	1,183.16	Direct	Form 4 ↗0001262388-26-000016
2026-08-17Filed 2026-08-18	LUCIANO JUAN RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	13.4527A	1,183.16	Direct	Form 4 ↗0000059478-26-000087
2026-08-17Filed 2026-08-18	Fyrwald J ErikDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	8.3815A	1,183.16	Direct	Form 4 ↗0000059478-26-000085
2026-08-10Filed 2026-08-11	Zakrowski Donald AOfficer · SVP, Finance, & CAO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	2,000D	1,185.01	Direct	Form 4 ↗0000059478-26-000083
2026-08-07Filed 2026-08-10	Hakim AnatOfficer · EVP, GC & Secretary Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2026. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	5,000D	1,190	IndirectBy spouse	Form 4 ↗0001685556-26-000006
2026-08-01Filed 2026-08-03	Seymour MelissaOfficer · EVP, Global Quality Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027. References: F1, F2	M Exercise / conversionRestricted Stock Unit · Derivative	981D	0	Direct	Form 4 ↗0002032089-26-000002
2026-08-01Filed 2026-08-03	Seymour MelissaOfficer · EVP, Global Quality Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027. References:	F WithholdingCommon Stock · Non-derivative	438.707D	1,148.84	Direct	Form 4 ↗0002032089-26-000002
2026-08-01Filed 2026-08-03	Seymour MelissaOfficer · EVP, Global Quality Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027. References:	M Exercise / conversionCommon Stock · Non-derivative	981A	0	Direct	Form 4 ↗0002032089-26-000002
2026-07-20Filed 2026-07-21	Alvarez RalphDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. References: F1	A Award / grantCommon Stock · Non-derivative	10.8263A	1,146.9	Direct	Form 4 ↗0001310215-26-000013
2026-07-20Filed 2026-07-21	Sulzberger GabrielleDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	4.3232A	1,146.9	Direct	Form 4 ↗0001262388-26-000014
2026-07-20Filed 2026-07-21	LUCIANO JUAN RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	13.878A	1,146.9	Direct	Form 4 ↗0000059478-26-000068
2026-07-20Filed 2026-07-21	Fyrwald J ErikDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	8.6465A	1,146.9	Direct	Form 4 ↗0000059478-26-000066
2026-06-15Filed 2026-06-16	Alvarez RalphDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. References: F1	A Award / grantCommon Stock · Non-derivative	10.9945A	1,129.35	Direct	Form 4 ↗0001310215-26-000011
2026-06-15Filed 2026-06-16	Sulzberger GabrielleDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	4.3904A	1,129.35	Direct	Form 4 ↗0001262388-26-000012
2026-06-15Filed 2026-06-16	LUCIANO JUAN RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	14.0937A	1,129.35	Direct	Form 4 ↗0000059478-26-000059
2026-06-15Filed 2026-06-16	Fyrwald J ErikDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. References: F1	A Award / grantCommon Stock · Non-derivative	8.7809A	1,129.35	Direct	Form 4 ↗0000059478-26-000057
2026-06-10Filed 2026-06-11	Yuffa IlyaOfficer · EVP&Pres, LLY USA&Global Capab Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	2,500D	1,150.77	Direct	Form 4 ↗0001826001-26-000006
2026-05-18Filed 2026-05-19	Alvarez RalphDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. F2 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. References: F1	A Award / grantCommon Stock · Non-derivative	12.566A	988.09	Direct	Form 4 ↗0001310215-26-000008

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.